---
title: 'Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health
  in postmenopausal women: a controlled cohort extension study'
date: '2023-07-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37522858/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230731181122&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: While these findings provide reassurance that short-to-medium-term
  exposure to AI therapy is not associated with metabolically adverse changes when
  compared to controls, risk evolution should be less focused on the AI-associated-effect,
  and more on the general development of cardiovascular risk over ...'
disable_comments: true
---
CONCLUSIONS: While these findings provide reassurance that short-to-medium-term exposure to AI therapy is not associated with metabolically adverse changes when compared to controls, risk evolution should be less focused on the AI-associated-effect, and more on the general development of cardiovascular risk over ...